Table 1 Patient characteristics between non-reversal and reversal groups after Hartmann’s procedure.
From: Analysis of factors affecting reversal of Hartmann’s procedure and post-reversal complications
All (n = 437) | Non HR (n = 310) | HR (n = 127) | P | |
|---|---|---|---|---|
Age (years) | 67.7 (13.8) | 70.2 (12.7) | 61.6 (14.3) | < 0.001 |
Male | 220 (50.3) | 157 (50.7) | 63 (49.6) | 0.844 |
BMI (kg/m2) | 22.8 (3.5) | 22.6 (3.6) | 23.4 (3.1) | 0.058 |
ASA | 0.034 | |||
I/II | 208 (48.0) | 139 (44.8) | 69 (56.1) | |
III/IV | 225(52.0) | 171 (55.2) | 54 (43.9) | |
Comorbidities | 273 (62.6) | 197 (63.8) | 76 (59.8) | 0.443 |
HTN | 199 (45.5) | 156 (50.3) | 43 (33.9) | 0.002 |
DM | 83 (19.0) | 68 (21.9) | 15 (11.8) | 0.014 |
Digestive disease | 9 (2.1) | 8 (2.6) | 1 (0.8) | 0.458 |
Pulmonolary disease | 20 (4.6) | 17 (5.5) | 3 (2.4) | 0.209 |
Cerebrovascular disease | 47 (10.8) | 41 (13.2) | 6 (4.7) | 0.009 |
Cardiologic disease | 27 (6.2) | 21 (6.8) | 6 (4.7) | 0.419 |
Nephrotic disease | 9 (2.1) | 8 (2.6) | 1 (0.8) | 0.458 |
Endocrinologic disease | 29 (6.6) | 22 (7.1) | 7 (5.5) | 0.546 |
Psychiatric disease | 4 (0.9) | 3 (1.0) | 1 (0.8) | 1.00 |
Othersa | 12 (2.7) | 12 (3.9) | 0 (0.0) | 0.022 |
Three or more | 27 (6.2) | 22 (7.1) | 5 (3.9) | 0.210 |
Previous op history | 127 (29.1) | 39 (30.7) | 88 (28.4) | 0.627 |
Previous cancer history | 53 (12.1) | 45 (14.5) | 8 (6.3) | 0.017 |
Diagnosis | 0.631 | |||
Malignancy | 227 (51.9) | 184 (59.4) | 43 (33.9) | |
Diverticulitis | 66 (15.1) | 35 (11.3) | 31 (24.4) | |
Trauma | 38 (8.7) | 15 (4.8) | 23 (18.1) | |
Fistula | 7 (1.6) | 6 (1.9) | 1 (0.8) | |
Severe adhesion | 3 (0.7) | 6 (1.9) | 1 (0.8) | |
Ischemia | 62 (14.2) | 41 (13.2) | 21 (16.5) | |
Volvulus | 7 (1.6) | 6 (1.9) | 1 (0.8) | |
Stercoral | 21 (4.8) | 17 (5.5) | 4 (3.1) | |
Othersb | 6 (1.4) | 4 (1.3) | 2 (1.6) | |
Tumor stage | 0.003 | |||
I | 8 (3.8) | 3 (1.6) | 5 (11.6) | |
II | 68 (30.0) | 54 (29.3) | 14 (32.6) | |
III | 97 (42.7) | 77 (41.8) | 20 (46.5) | |
IV | 54 (23.8) | 50 (27.2) | 4 (9.3) | |
